Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccine
Immunological prevention of multigene cancer syndrome
February 10th, 2005
Researchers present strategies for the immunological prevention of multigene cancer syndrome in a recent issue of Cancer Research. According to published research from Italy, "Vaccines effectively prevent the onset of tumors in transgenic mice carrying activated oncogenes; however, human tumors are caused by combined alterations in oncogenes and oncosuppressor genes. We evaluated the impact of prophylactic vaccines in HER-2/neu transgenic, p53 wild-type/null mice that succumb to an aggressive cancer syndrome comprising mammary and salivary gland carcinomas and rhabdomyosarcoma." "A vaccine made of allogeneic mammary carcinoma cells expressing...
Source: Women's Health Weekly (2005-02-10)
|
